Jing He

Jing He, Research Analyst, joined Casdin Capital in 2021 and focuses on therapeutics. Jing brings 10 years of experience in both investment management and pharmaceutical industry.

Prior to joining Casdin, Jing served as a healthcare portfolio manager and analyst at Gabelli Funds where she covered the biopharmaceutical industry. Her prior experience includes time at Alliance Bernstein and SVB Leerink. She began her career at Regeneron Pharmaceuticals as a scientist in drug research and development where she worked on drugs including Eylea, Dupixent and Praluent.

Jing earned an MBA from Columbia Business School, a Masters in Chemistry from Washington University in St. Louis and a B.S. in Chemistry from Peking University.